T. Rowe Price Investment Management
NBIX icon

T. Rowe Price Investment Management’s Neurocrine Biosciences NBIX Stock Holding History

T. Rowe Price Investment Management’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,008,326
Closed -$107M – 558
2022
Q3 		$107M Buy
+1,008,326
New +$107M 0.09% 229